WisdomTree Global ex-U.S. Quality Growth Fund DNL
42.26 USD -0.80 (-1.85%)
Nov 10, 2026, 1:30 PM EST
42.26 Day range 42.92
38.87 52-week range 47.46
- YTD
- +2.53%
- 1 year
- +2.65%
News
globenewswire.com Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights AVLAYAH® (tividenofusp alfa-eknm) net product revenue accelerated to $17.8 million in its second full commercial quarter Continued growth expectations drive Q4 2026 net product revenue guidance of…
benzinga.com What's Going On With Shopify Stock Tuesday? Shopify (SHOP) fell nearly 8% as investors rotated away from high-multiple growth stocks despite strong Q2 earnings. Learn more.
benzinga.com Denali Therapeutics Late Wednesday Announces Pricing Of $275M Public Offering Of 10,377,359 Shares Of Common Stock For $26.50 Per Share Denali Therapeutics Inc. (NASDAQ:DNLI) today announced the pricing of its underwritten public offering of 10,377,359 shares of its common stock at a price to the public of $26.50 per share. All of…
benzinga.com New ETF Brings Dividend Growth Concept to Emerging Markets 
benzinga.com Three Ex-U.S. ETFs Your Broker Forgot to Mention 
benzinga.com 4 "Ex" ETFs Your Broker Forgot to Mention (DTN, AXEN, FDT) 
benzinga.com Immunomedics Reports Clinical Results of Pretargeted Radioimmunotherapy of Colorectal Cancer 
benzinga.com Five International Dividend ETFs Your Broker Forgot to Mention - benzinga.com Immunomedics Reports First Clinical Results of New Antibody-Directed Radiation Therapy for Colorectal Cancer
- benzinga.com Goldman Sachs Expects A Correction In Asian Stocks In 2010 (EWY, FXI, SCJ, DNL)